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Nucleoside triphosphate diphosphohydrolase (NTPDase) activity was recently characterized in Leishmania
(Viannia) braziliensis promastigotes (Lb), and an antigenic conserved domain (r82–121) from the speciﬁc
NTPDase 1 isoformwas identiﬁed. In thiswork,mouse polyclonal antibodies produced against two synthetic
peptides derived from this domain (LbB1LJ, r82–103; LbB2LJ, r102–121) were used. The anti-LbB1LJ or anti-
LbB2LJ antibodies were immobilized on protein A-sepharose and immunoprecipitated the NTPDase 1 of
48 kDa and depleted approximately 40% of the phosphohydrolytic activity from detergent-homogenized
Lb preparation. Ultrastructural immunocytochemical microscopy identiﬁed the NTPDase 1 on the parasite
surface and in its subcellular cytoplasmic vesicles, mitochondria, kinetoplast and nucleus. The ATPase and
ADPase activities of detergent-homogenized Lbpreparationwere partially inhibited by anti-LbB1LJ antibody
(43–79%), which wasmore effective than that inhibition (18–47%) by anti-LbB2LJ antibody. In addition, the
immune serum anti-LbB1LJ (67%) or anti-LbB2LJ (33%) was cytotoxic, signiﬁcantly reducing the promastig-
otes growth in vitro. The results appoint the conserved domain from the L. braziliensis NTPDase as ansevier OA license. 
Bioquímica, ICB, Universidade Federal de Juiz de Fora, Rua José Lourenço Kelmer s/n, Campus Universitário, Bairro São
2 2102 3216.
.G. Vasconcelos).
294 G.N. Porcino et al. / Experimental Parasitology 132 (2012) 293–299important target for inhibitor design and the potential application of these biomolecules in experimental
protocols of disease control.
 2012 Elsevier Inc. Open access under the Elsevier OA license.Fig. 1. (A) Reactivity of active NTPDase 1 from L. braziliensis promastigote with
polyclonal anti-peptides antibodies. An aliquot (100 lg of protein) of L. braziliensis
promastigote preparation (Wb, A and B) was submitted to electrophoresis in 10%
SDS–PAGE, electroblotted onto nitrocellulose membrane, and the Western blots
was developed with mouse polyclonal serum (dil. 1:200) against LbB1LJ (A) or
LbB2LJ (B). In Wb-I, immunoprecipitated protein A-mouse antibody–antigen
complex isolated from promastigote preparation by mouse polyclonal anti-LbB1LJ
(C) or anti-LbB2LJ (D) antibodies was electrophorezed and electroblotted under
same conditions, and developed with rabbit polyclonal serum against potato
apyrase (dil. 1:1000). The membranes were revealed by chemiluminescence. (B)
Alignment of primary amino acid sequence of the synthetic peptide LbB1LJ (A) or
LbB2LJ (B) and its counterpart within putative proteins from Leishmania spp.⁄. The
identical amino acid residues of the peptides LbB1LJ and LbB2LJ are shown as grey
columns. GenBank accession numbers of the amino acid sequences are: L.
braziliensis ATPDase 1, ⁄XP_001562178, L. infantum ATPDase, CAM66723.1; L. major
NDPase, CAJ03227.1; L. mexicana NDPase, CBZ25018.1; L. donovani ATPDase,
CBZ32820.1; L. braziliensis GDPase, XP_001562788.1. Introduction
Leishmania (Viannia) braziliensis is a protozoan parasite trans-
mitted by the bite of female phlebotomine sandﬂies. It is found
throughout Brazil and causes American cutaneous leishmaniasis,
a disease characterized by the development of single or multiple
cutaneous lesions (Marques et al., 2006; Passos et al., 1999). The
structural organization and metabolism of Leishmania spp. have
been studied and several proteins have been indicated as potential
targets of antileishmanial drugs (Costa et al., 2011; Cuervo et al.,
2009; De Souza, 2008; Silverman et al., 2008).
The nucleoside triphosphate diphosphohydrolase (NTPDase; EC
3.6.1.5), which is also named apyrase in plants, and ATP diphos-
phohydrolase, NTPDase or NTPase in parasites, hydrolyzes di-
and triphosphate nucleosides to the corresponding nucleoside
monophosphates upon bivalent metal ion activation. These ubiqui-
tous enzymes are insensitive to the F-, P- and V-type ATPases
inhibitors and share ﬁve apyrase-conserved regions (ACR1–ACR5)
that are involved in the catalytic cycle (Coimbra et al., 2002; Far-
ia-Pinto et al., 2004; Guevara-Flores et al., 2008; Kettlun et al.,
2005; Knowles, 2011; Ruckert et al., 2010; Sansom, 2012). Biolog-
ical actions of NTPDases are related to the regulation of nucleo-
tides, and are involved in several physiological processes such as
purinergic signaling systems, and infectivity and/or purine recu-
peration by protozoan parasites, and these proteins have been ap-
pointed as possible targets for the treatment of several diseases
(Burnstock and Verkhratsky, 2009; Gendron et al., 2002; Kikuchi
et al., 2001; Meyer-Fernandes et al., 2010; Paletta-Silva and
Meyer-Fernandes, 2012; Penido et al., 2007; Pinheiro et al., 2006;
Sansom, 2012; Santos et al., 2009; Souza et al., 2010; Tan et al.,
2010).
Recently, an active and antigenic NTPDase isoform, the NTP-
Dase 1, was characterized in L. braziliensis promastigotes (Rez-
ende-Soares et al., 2010), the ﬁrst stage of host–parasite
interaction that includes modulation of the immune response
and host–cell signaling (Cuervo et al., 2009; De Souza, 2008). By
experimental and in silico analyses we identify a particular con-
served domain, named B, within L. braziliensis NTPDase 1, which
is also shared with potato apyrase and NTPDases of other plants
and pathogenic organisms of distinct phylogenetic lineages. The
domain B did not include amino acids sequences of ACRs, and it
was associated to antigenicity in human parasite diseases, and also
seems to be conserved during host and parasites co-evolution
(Coimbra et al., 2008; Faria-Pinto et al., 2004, 2006, 2008,
2010a,b Maia et al., 2011; Mendes et al., 2011; Rezende-Soares
et al., 2010; Vasconcelos et al., 2009).
In preliminary analysis, the localization of NTPDase activity in L.
braziliensis promastigote forms was obtained by ultrastructural
cytochemical (Rezende-Soares et al., 2010), but this technique
did not distinguish the NTPDase 1 and a putative GDPase (Peacock
et al., 2007; XP_001562788), also annotated in the genome of this
parasite. In this work, mouse polyclonal antibodies against two
synthetic peptides (LbB1LJ, r82–103; LbB2LJ, r102–121) belonging
to the domain B from the L. braziliensis NTPDase 1 (Peacock et al.,
2007; XP_001562178) were used for speciﬁc identiﬁcation and
localization of this protein in promastigote forms. In addition, the
effects of mouse polyclonal anti-peptide antibodies on the NTP-
Dase 1 activity, using a suitable reaction medium for both bio-
chemical and immunological assays, and in vitro proliferation of
L. braziliensis promastigotes were tested.2. Material and methods
2.1. Potato apyrase, synthetic peptides and development of polyclonal
antibodies
Potato apyrasewas puriﬁed from a commercial strain of Solanum
tuberosum and used to obtain polyclonal antiserum in a New Zea-
land white rabbit (Faria-Pinto et al., 2004; Kettlun et al., 2005).
The LbB1LJ (r82–103; Fig. 1B; Rezende-Soares et al., 2010) and
LbB2LJ (r102–121, Fig. 1B) belonging to a conserved domain from
L. braziliensis NTPDase 1 (Peacock et al., 2007; XP_001562178.1;
47,689 Da) were obtained by solid-phase peptide synthesis as ear-
lier described (Korkmaz et al., 2008). Themolecularmass and purity
of synthesized peptides were conﬁrmed by amino acid analysis and
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Daltonics, Billerica, MA, USA). These peptides span the domain B
(r82–121) within L. braziliensis NTPDase 1 overlapping two amino
acids at LbB1LJ C-terminus and at LbB2LJ N-terminus. They main-
tain the predicted epitopes available for antibody binding (Faria-
Pinto et al., 2008; Vasconcelos et al., 2009).
Polyclonal immune serum against each peptide (10 lg) was ob-
tained from seven-week old BALB/c mice that were inoculated by a
peritoneal route emulsiﬁed in Freund’s complete and incomplete
adjuvant, delivered in 15-day interval as early described (Mendes
et al., 2011). In addition, pooled serum samples obtained from
BALB/cmice thatwere inoculated under the same experimental con-
ditions with both complete and incomplete Freund adjuvant in the
absence of the peptide were used for speciﬁcity control in all exper-
iments (Mendes et al., 2011). The sera were stored at 20 C. The
study protocols complied with the regulations of the Brazilian Na-
tional Council of Research in Animals andwere approved by the Eth-
ical Committee for Animal Research of the Universidade Federal de
Juiz de Fora, Juiz de Fora, MG, Brazil, under process no.012/2011.
2.2. Identiﬁcation of active NTPDase 1 by immunoprecipitation assays
Promastigote preparations from L. (V.) braziliensis MHOM/BR/
1975/M2903 strain were obtained as described elsewhere (Rez-
ende-Soares et al., 2010). An aliquot of promastigotes preparation
was suspended in standard reaction medium containing 50 mM
MOPS (3-(N-morpholino) propanesulfonic acid) buffer, pH 7.4,
1 mM CaCl2, 100 lM sodium orthovanadate supplemented with
1 mg/ml dodecyl nonaethylene glycol ether (C12E9). After centrifu-
gation at 10,000g for 10 min at 4 C, mouse immune serum anti-
LbB1LJ or anti-LbB2LJ at a ﬁnal dilution of 1:200was added to the ali-
quots of high-speed supernatant (5 mg protein/ml) and incubated
for 3 h at room temperature. Assays using control serum were run
in parallel. Protein A-Sepharose was added and incubated for an
additional 2 h. Supernatants were used for phosphohydrolytic activ-
itymeasurements in triplicate in standard reactionmediumcontain-
ing 0.1 mg protein/ml. The reaction was initiated by addition of
3 mM ATP or ADP, allowed to proceed for 60 min at 37 C, and the
amount of inorganic phosphate (Pi) liberated was determined spec-
trophotometrically (Rezende-Soares et al., 2010). The experiments
were repeated twice. The resin-mouse antibody–antigen complexes
were sedimented by centrifugation for 5 min, washed 3 times in
50 mM MOPS buffer, pH 7.4, solubilized in gel loading buffer and
submitted to sodium dodecyl sulfate-10% polyacrylamide gel elec-
trophoresis (SDS–PAGE), using Mini-Protean III Cell (Bio-Rad). The
proteins were electroblotted onto nitrocellulose membranes, fol-
lowed by blocking step (0.15 M phosphate buffer solution, pH 7.4,
plus 0.3% Tween-20 and 2% casein) using standard procedures (Rez-
ende-Soares et al., 2010). To avoid reactivity with subunits from
mouse-IgG, rabbit immune serum (diluted 1:1000) containing poly-
clonal anti-potato apyrase antibodies, diluted in the same blocking
buffer without Tween-20, were incubated overnight. Total proteins
(100 lg) of L. braziliensis promastigote preparations were also sub-
mitted to electrophoresis in 10% SDS–PAGE and electroblotted onto
nitrocellulose membranes, and developed with immune serum
anti-LbB1LJ or anti-LbB2LJ (diluted 1:200). Signals were revealed
by chemiluminescence using anti-rabbit IgG or anti-mouse IgG anti-
body coupled to horseradish peroxidase and luminol as substrate
(ECL Western blotting system; GE Healthcare, Brazil) and exposed
to X-ray ﬁlm following the manufacturer’s instructions.
2.3. Effects of mouse polyclonal anti-peptide antibodies on the
phosphohydrolytic activity
Aliquot of promastigotes preparation was homogenized in
C12E9, centrifuged, and the supernatant was incubated for 3 hwith serum containing mouse polyclonal anti-peptide antibodies
or mouse control serum at a ﬁnal dilution of 1:200 exactly as de-
scribed in Section 2.2. Aliquots were used for phosphohydrolytic
activity measurements in triplicate in standard reaction medium.
The assays were repeated in three different experiments.
2.4. Ultrastructural immunocytochemistry
For analysis by transmission electron microscopy, the prom-
astigotes were ﬁxed in freshly prepared 4% paraformaldehyde/
0.1% glutaraldehyde and 0.2% picric acid in a 0.1 M sodium caco-
dylate buffer, pH 7.2. Samples were dehydrated in methanol at
progressively lower temperatures, embedded in Lowicryl K4 M re-
sin (Polysciences, Inc., PA, USA) and maintained at –20 C. Ultrathin
sections were collected on 300 mesh nickel grids and incubated for
30 min at 25 C in 50 mM ammonium chloride in 0.1 M PBS, pH
8.0. Afterward, sections were incubated for 10 min at room tem-
perature in PBS containing 3% BSA and 0.2% Tween 20 (PBS–BSA–
TW), pH 8.0 and then incubated overnight in the presence of im-
mune serum anti-LbB1LJ, anti-LbB2LJ or control serum diluted
1:100. Grids were rinsed in PBS–BSA and, ﬁnally, incubated for
60 min with a 1:20 dilution of goat anti-mouse antibody conju-
gated with 10 nm gold particles (Sigma Chemical Co., St. Louis,
MO, USA). The grids were subsequently washed with PBS and dis-
tilled water, stained with uranyl acetate and observed in a Jeol
1011 transmission electron microscope from Electronic Micros-
copy Platform of the Oswaldo Cruz Institute, FIOCRUZ, Rio de
Janeiro, RJ, Brazil.
2.5. In vitro antileishmanial activity
The antileishmanial activity of the polyclonal anti-LbB1LJ or
anti-LbB2LJ antibodies was determined by the colorimetric
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide
(MTT) method based on tetrazolium salt reduction by mitochon-
drial dehydrogenases, as earlier described (Coimbra et al., 2010).
Brieﬂy, mouse polyclonal anti-peptide antibodies at a ﬁnal dilution
of 1:100 were incubated for 24 h with promastigotes from a loga-
rithmic phase growth. Controls containing medium alone, or serum
samples (diluted 1:100) from either healthy rabbit or BALB/c mice
pre-inoculated with complete and incomplete Freund adjuvant in
the absence of the peptide (mouse control serum) were also in-
cluded in this assay. All serum samples were previously incubated
at 56 C for 30 min for the complete inactivation of the comple-
ment system. Absorbance was measured at 570 nm (Multiskan
MS microplate reader, LabSystems Oy, Helsink, Finland). Ampho-
tericin B (Cristália, São Paulo, Brazil) was used as a control. The
analysis was made in triplicate in three separate experiments,
and the results represent the mean ± standard deviation. Data were
analyzed statistically by the Student’s t-test with the level of signif-
icance set at P < 0.05.3. Results
3.1. Identiﬁcation of active NTPDase 1 isoform by
immunoprecipitation assays
In Western blots of L. braziliensis promastigote preparation
(Fig. 1A), mouse polyclonal anti-LbB1LJ (Wb, lane A) or anti-LbB2LJ
(Wb, lane B) antibodies recognized bands of approximately 48 and
43 kDa. Mouse control serum diluted 1:200 did not react with this
preparation (data not shown). In addition, under employed exper-
imental conditions, mouse polyclonal anti-LbB1LJ antibodies
immobilized on Protein A-Sepharose immunoprecipitated approx-
imately 30% of the ATPase and 40% of the ADPase activity whereas
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ADPase activity from the L. braziliensis promastigote preparations
(Table 1). The immunoprecipitated resin-mouse antibody–antigen
complexes were washed and subjected to electrophoresis and
Western blots. As observed in Fig. 1A, the mouse polyclonal anti-
LbB1LJ or anti-LbB2LJ antibodies immobilized on Protein A-Sephar-
ose immunoprecipitated the same bands of approximately 48 and
43 kDa from the promastigote preparation (Wb-I, lanes C and D),
which were recognized by the rabbit polyclonal anti-potato apy-
rase antibodies (Fig. 1A).
The primary amino acid sequence of the synthetic peptide
LbB1LJ (A) or LbB2LJ (B) that belongs to the conserved domain B
from Leishmania braziliensis NTPDase 1 was aligned with its coun-
terpart within putative proteins from Leishmania spp. (Fig. 1B).
3.2. Immunolocalization of the NTPDase 1 from L. braziliensis
promastigotes
Localization of the NTPDase 1 was obtained by ultrastructural
immunocytochemical techniques using either mouse polyclonal
anti-LbB1LJ or anti-LbB2LJ antibodies and a colloidal gold-conju-
gated secondary antibody (Fig. 2). The gold immunocomplexes of
anti-LbB1LJ (A–D) and anti-LbB2LJ antibodies (E–F) appeared on
the outer surface of the plasma membrane, at cytoplasmic vesicles,
ﬂagellar pocket (FP), ﬂagellum (F), mitochondria (M), kinetoplast
(K) and nucleus (N). Promastigote forms incubated with mouse
control serum showed no gold particle labeling (data not shown).
3.3. Mouse polyclonal anti-peptide antibodies inhibit the NTPDase 1
activity from L. braziliensis promastigotes preparation
The effect of mouse polyclonal anti-peptide antibodies binding
on phosphohydrolytic activity from the L. braziliensis NTPDase 1
was tested using the detergent-homogenized preparations and a
standard reaction medium (Table 2). Under experimental condi-
tions employed, polyclonal antibodies against LbB1LJ signiﬁcantly
inhibited (P < 0.01) the ATPase (79%) or ADPase (43%) activity of
promastigotes preparation when compared to the control (Table 2).
Polyclonal antibodies against LbB2LJ also signiﬁcantly inhibited
(P < 0.05) the ATPase activity (47%) of promastigotes preparation
when compared to the control and, to a lesser extent, the ADPase
activity (Table 2; 18%).
3.4. Antileishmanial activity
The effects of the mouse polyclonal anti-peptides on the in vitro
proliferation of L. braziliensis promastigotes were tested (Fig. 3). The
promastigotes growthwas signiﬁcantly inhibited in the presence of
anti-LbB1LJ (67%; P < 0.01) or anti-LbB2LJ (33%; P < 0.05) antibodies
when compared to themouse control serum,which represents 100%
cell growth (Fig. 3; C3). The promastigotes growth inmedium aloneTable 1
Depletion of NTPDase 1 activity from detergent-homogenized promastigotes prep-
aration by mouse polyclonal anti-peptides antibodies immobilized on Protein A-
Sepharose.
Experimental conditionsa ATPase activityb ADPase activityb
nmol Pi mg1 min1 nmol Pi mg1 min1
Control 18.7 ± 1.7 6.6 ± 2
Immune serum anti-LbB1LJ 13.2 ± 0.7 (70) 3.9 ± 0.1 (60)
Immune serum anti-LbB2LJ 8.8 ± 0.2 (47) 3.7 ± 1.1 (56)
a Mouse control serum or immune serum diluted 1:200.
b The result is the mean ± standard deviation of two different experiments made
in triplicate. In parenthesis, percentage of hydrolytic activity compared to the
control.(C1), or with serum samples from either healthy rabbit (C2) or
mouse control serum (C3) were similar among them (Fig. 3).4. Discussion
In this work we showed that mouse polyclonal antibodies pro-
duced against synthetic peptides LbB1LJ (r82–103) and LbB2LJ
(r102–121), which span the antigenic and conserved domain B
within L. braziliensis NTPDase 1, identiﬁed two bands of approxi-
mately 48 and 43 kDa in Western blots of both total homogenized
and immunoprecipitated resin-mouse antibody–antigen com-
plexes. These polyclonal antibodies immobilized on Protein A-Se-
pharose immunodepleted approximately 40% of the NTPDase
activity from the L. braziliensis promastigotes preparation, remain-
ing in the soluble fraction either NTPDase 1 insufﬁciently depleted
or enzyme activity from the putative GDPase (MW 75 kDa) from L.
braziliensis genome (Peacock et al., 2007), this last one still not
characterized in this parasite. It is interesting to observe that no
signiﬁcant identity was found between the synthetic peptide
LbB1LJ or LbB2LJ and its counterpart within putative L. braziliensis
GDPase (Fig. 1B). The results conﬁrmed the previous identiﬁcation
of the NTPDase 1, obtained by the cross-immunoreactivity with
potato apyrase (Rezende-Soares et al., 2010) or r-potDomain B, a
recombinant polypeptide obtained as a 6xHis tag polypeptide
belonging to the domain B (r78–117) from the potato apyrase
(Maia et al., 2011). The band of 43 kDa possibly resulted of
in vivo proteolytic posttranslational processing of the L. braziliensis
NTPDase 1, as previously observed (Maia et al., 2011; Rezende-
Soares et al., 2010). Taken together, these results showed the spec-
iﬁcity, sensitivity and afﬁnity of mouse polyclonal anti-LbB1LJ or
anti-LbB2LJ antibodies for the epitopes within amino acids resi-
dues r82–121 from the L. braziliensis NTPDase 1, an important tar-
get for inhibitor design. The domain B is highly conserved within
putative NTPDases of Leishmania infantum and Leishmania major
(Peacock et al., 2007), as shown by Maia et al. (2011) and, also,
of Leishmania donovani and Leishmania mexicana, recently anno-
tated in the respective genomes (Fig. 1B). Thus, the results suggest
a potential application of these antibodies for the study of the
structure and function of this protein and, also, of other parasite
NTPDase isoforms that share the domain B (Maia et al., 2011).
Parasite NTPDase isoforms have been described by us and by
other authors as ecto-enzymes on the parasite surface (Coimbra
et al., 2002; Faria-Pinto et al., 2004, 2006; Guevara-Flores et al.,
2008; Kikuchi et al., 2001; Meyer-Fernandes et al., 2010; Pinheiro
et al., 2006; Ruckert et al., 2010; Sansom, 2012; Santos et al.,
2009). Now, by immunocytochemical techniques,mouse polyclonal
anti-LbB1LJ or anti-LbB2LJ antibodies speciﬁcally identiﬁed pro-
mastigote NTPDase 1 at the surface of the plasmamembrane, in ﬂa-
gellar pocket and ﬂagellum, mitochondria and kinetoplast, in
according to the cytochemical method (Rezende-Soares et al.,
2010) and, also, in nucleus and associatedwith cytoplasmic vesicles.
The parasite use environment metabolites as energy source for its
growth and morphological changes during its life cycle. It is by
means of the cell surface that the parasite interacts with its host,
either by the direct participation of surface-associated proteins or
by secretion of proteins, being the ﬂagellar pocket an organelle with
intense endocytic and exocytic activities in Leishmania (Costa et al.,
2011; Cuervo et al., 2009; De Souza, 2008; Silverman et al., 2008).
This ubiquitous distribution of NTPDase 1 in promastigotes suggests
its participation in several metabolic pathways potentially involved
in nucleotides modulation in early stages of Leishmania infection.
The ATPase (79%) and ADPase (43%) activities of detergent-
homogenized L. braziliensis preparation were partially inhibited
by anti-LbB1LJ antibody, whichwasmore effective than that inhibi-
tion of ATP (47%) or ADP (18%) hydrolysis by anti-LbB2LJ antibody
Fig. 2. Electron micrographs showing the localization of NTPDase 1 in L. braziliensis promastigotes using immune serum anti-LbB1LJ (A–D) or anti-LbB2LJ (E–F) and a colloidal
gold-conjugated secondary antibody. Gold immunocomplexes of anti-peptide antibody are distributed (A, D) at the outer surface of plasma membrane (arrow), nucleus
(arrow), mitochondria and kinetoplast (arrowheads); (B) at ﬂagellar pocket and ﬂagellum (white arrows); (C) nucleus and nucleus in division (arrows). Using anti-LbB2LJ
antibody, the NTPDase 1 was identiﬁed in the same sites, and gold immunocomplexes are shown (E, F) at mitochondria and kinetoplast (arrowheads); ﬂagellar pocket and
ﬂagellum (white arrows), cytoplasmic vesicles (arrow) and nucleus (arrow). FL: ﬂagellum; FP: ﬂagellar pocket; K: kinetoplast; N: nucleus. Bar = 0.05 lm.
Table 2
NTPDase 1 activity inhibition by polyclonal anti-LbB1LJ or anti-LbB2LJ antibodies.
Experimental conditionsa ATPase activityb ADPase activityb
nmol Pi mg1 min1 nmol Pi mg1 min1
Control 17.9 ± 2.7 8.0 ± 2.0
Immune serum anti-LbB1LJ 3.8 ± 2.4 (21)** 4.6 ± 1.3 (57)**
Immune serum anti-LbB2LJ 9.5 ± 0.4 (53)* 6.6 ± 1.4 (82)
In parenthesis, percentage of hydrolytic activity compared to the control.
a Mouse control serum or immune serum diluted 1:200.
b Result is the mean ± standard deviation of three different experiments made in
triplicate.
* P value is 0.05.
** P value is 0.01.
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properties is within r82–103 from L. braziliensis NTPDase 1. The sig-
niﬁcant ATPase activity inhibition by anti-LbB2LJ antibody that
binds r102–121, and its lower efﬁciency for ADPase activity inhibi-
tion, appears to indicate that the domain B of the NTPDase 1 partic-
ipates in nucleotides modulation, again appointing it as an
important target for inhibitor design. Since antibodies could has
site for calcium, and high molar concentration (1–10 mM) of this
bivalent ion could inhibit antibody–antigen binding (Beck et al.,
2007; Zhou et al., 2005), we established a suitable standard reaction
medium for both immunological and biochemical assays that was
useful for isolation of L. braziliensis NTPDase 1 from promastigotes
preparation by immunoprecipitation assays, as shown here and in
previousworks (Maia et al., 2011; Rezende-Soares et al., 2010). Pos-
sibly this reaction medium maintains the NTPDase 1 closer to its
Fig. 3. Antileishmanial activity. The L. braziliensis promastigotes were maintained
in 96-well microtiter plates at 24 C and exposed to mouse polyclonal serum anti-
LbB1LJ (LbB1LJ) or anti-LbB2LJ (LbB2LJ) at dilution 1:100 for 24 h. Control
containing medium alone (C1), serum sample from healthy rabbit (C2; diluted
1:100) or mouse control serum (C3; diluted 1:100) were also included in this assay.
The antileishmanial activity was determined by the colorimetric MTT method. The
results are expressed as the mean of the optical density ± S.D. of three different
experiments performed in triplicate. The statistical signiﬁcance of difference
between mouse control serum (C3, 100% cell growth) and immune serum was
determined using Student t test. P value is ⁄0.05 or ⁄⁄0.01.
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et al., 2008; Maia et al., 2011), its domain B exposed for antibody
binding. These new data could to orient site-directed mutagenesis
within Domain B from an active recombinant of the L. braziliensis
NTPDase 1, identifying the amino acid residues that likely interact
with the antibodies.
These results stimulate us to test the L. braziliensis promastig-
otes sensitivity to antibody-mediated growth inhibition in vitro,
and the two immune sera were signiﬁcantly cytotoxic. The im-
mune serum anti-LbB1LJ that inhibits with more efﬁciency the
NTPDase 1 activity reduces 67%, whereas immune serum anti-
LbB2LJ reduces 33% the promastigotes growth, suggesting a direct
antibody binding which distinctly inhibits enzyme activity and
causes the death of the parasite. A polyclonal immune serum
against Trypanosoma cruzi NTPDase 1 signiﬁcantly inhibited the
infectivity of trypomastigotes in vitro (Santos et al., 2009). In previ-
ous studies, the antigenicity of Toxoplasma gondii NTPDase iso-
forms was revealed (Asai et al., 1992), and its catalytic activity
was almost totally inhibited by monoclonal antibodies (Kikuchi
et al., 2001). Recently was shown that monoclonal antibodies
against antigenic T. gondii NTPase II inhibited its catalytic activity
and signiﬁcantly reduced the infectivity of tachyzoites (Tan et al.,
2010). In addition, a recombinant form of the T. gondii NTPase II
elicits a strong humoral and cellular immune responses in BALB/c
mice inducing partial protection against virulent T. gondii strains,
and it was indicated as an effective candidate for the development
of a vaccine against toxoplasmosis (Tan et al., 2011). Rabbit poly-
clonal anti-potato apyrase antibodies (Faria-Pinto et al., 2006) or
mouse polyclonal antibodies against a synthetic peptide (r175–
194) belonging to the domain B from the Schistosoma mansoni ATP-
Dase 2 (Mendes et al., 2011) did not recognize mammalian NTPD-
ases, corroborated by the lower identity found between domains B
from either potato apyrase or parasites and mammalian NTPDases
(Faria-Pinto et al., 2008; Maia et al., 2011). We hypothesize that the
synthetic peptides LbB1LJ or LbB2LJ, or its derivatives, could induce
immune response capable to inhibit invading promastigote forms,
and could be tested in experimental protocols of vaccine.Acknowledgments
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